Ang tanan nga mga Categories

Panimalay>Products>Nahuman nga Mga Produkto sa Pharmaceutical>Cardiovascular & Pag-ihi

Tranexamic Acid Injection


Dali nga Detalye:

2ml: 0.2g



Suportahi ang OEM/ODM:Oo

MOQ:500,000 Amps

Panahon sa delivery:30 ~ 55 Adlaw

Termino sa Pagbaligya:FOB, CIF

Termino sa Pagbayad:T / T, L / C

Standard Anaa:CP,BP

Dokumento:GMP, CPP, FSC, CTD



1. This product is primarily used for all types of bleeding due to acute or chronic, limited or systemic primary fibrinolysis. It is generally not used in secondary hyperfibrinolytic states caused by disseminated intravascular coagulation prior to heparinization.

2. For trauma or surgical bleeding in fibrinogen-rich organs such as prostate, urethra, lung, brain, uterus, adrenal gland and thyroid.

3. Used as an antagonist of tissue-type fibrinogen activator (t-PA), streptokinase and urokinase.

4. For fibrinolytic bleeding due to miscarriage, early placental abruption, stillbirth and amniotic fluid embolism, and increased menorrhagia due to localized fibrinolytic lesions in the uterine cavity.


Mga dili maayo nga reaksyon

1. Occasionally, there is intracranial thrombosis and bleeding due to drug overdose.

2.There may be diarrhea, nausea, and vomiting.

3.Less commonly, there is menstrual discomfort (due to blood clotting during menstruation).4 Because the product can enter the cerebrospinal fluid, central nervous system symptoms such as blurred vision, headache, dizziness, and fatigue may occur after injection, especially in relation to the rate of injection, but are rare.





Tipigi sa bugnaw, uga ug ngitngit nga dapit.

Ipahilayo ang tanang tambal sa bata.